Pulmonary Panel NGS Genetic Test
Test Name: Pulmonary panel NGS Genetic DNA Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test type: Cardiovascular Pneumology Disorders
Doctor: Cardiologist
Test Department: Genetics
Pre Test Information:
Clinical History of Patient who is going for Pulmonary panel NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ABCA3, ABCC8, ACVRL1, AP3B1, ASCL1, BLOC1S3, BLOC1S6, BMPR1B, BMPR2, CAV1, CCDC39, CCDC40, CFTR, CHAT, CHRNA1, CHRNB1, CHRND, CHRNE, COLQ, CSF2RA, CSF2RB, DKC1, DNAAF1, DNAAF2, DNAH11, DNAH5, DNAH9, DNAI1, DNAI2, DNAL1, DOCK8, DTNBP1, ECE1, EDN3, EFEMP2, EIF2AK4, ELN, ENG, FBLN5, FBN1, FLCN, FOXF1, GDF2, GDNF, GLRA1, HPS1, HPS3, HPS4, HPS5, HPS6, ITGA3, KCNA5, KCNK3, MECP2, NF1, NFU1, NKX2-1, NME8, NOP10, NOTCH3, PARN, PHOX2A, PHOX2B, POLD1, RAPSN, RASA1, RET, RSPH1, RSPH4A, RSPH9, RTEL1, SARS2, SCN4A, SCNN1A, SCNN1B, SCNN1G, SERPINA1, SFTPA2, SFTPB, SFTPC, SLC6A5, SLC7A7, SMAD4, SMAD9, SMPD1, STAT3, STRA6, TERT, TINF2, TSC1, TSC2, ZEB2
Test Details:
The Pulmonary Panel NGS Genetic DNA Test is a genetic test that uses next-generation sequencing (NGS) technology to analyze a patient’s DNA for mutations that may be associated with pulmonary diseases. This test can identify mutations in genes that are known to be associated with a variety of pulmonary conditions, including cystic fibrosis, alpha-1 antitrypsin deficiency, and pulmonary hypertension.
NGS technology allows for the analysis of multiple genes at once, making it a more efficient and comprehensive approach to genetic testing. The results of the Pulmonary Panel NGS Genetic DNA Test can help physicians diagnose and manage pulmonary diseases, as well as provide information about potential risks for family members.
This test is typically ordered for patients with symptoms of pulmonary disease or a family history of pulmonary conditions. It may also be recommended for individuals who are planning to start a family and want to assess their risk for passing on genetic mutations to their children.
It is important to note that genetic testing is not a replacement for clinical evaluation and diagnosis by a healthcare professional. The results of genetic testing should be interpreted in the context of a patient’s medical history and other clinical factors.
| Test Name | Pulmonary panel NGS Genetic DNA Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Cardiovascular Pneumology Disorders |
| Doctor | Cardiologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for Pulmonary panel NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ABCA3, ABCC8, ACVRL1, AP3B1, ASCL1, BLOC1S3, BLOC1S6, BMPR1B, BMPR2, CAV1, CCDC39, CCDC40, CFTR, CHAT, CHRNA1, CHRNB1, CHRND, CHRNE, COLQ, CSF2RA, CSF2RB, DKC1, DNAAF1, DNAAF2, DNAH11, DNAH5, DNAH9, DNAI1, DNAI2, DNAL1, DOCK8, DTNBP1, ECE1, EDN3, EFEMP2, EIF2AK4, ELN, ENG, FBLN5, FBN1, FLCN, FOXF1, GDF2, GDNF, GLRA1, HPS1, HPS3, HPS4, HPS5, HPS6, ITGA3, KCNA5, KCNK3, MECP2, NF1, NFU1, NKX2-1, NME8, NOP10, NOTCH3, PARN, PHOX2A, PHOX2B, POLD1, RAPSN, RASA1, RET, RSPH1, RSPH4A, RSPH9, RTEL1, SARS2, SCN4A, SCNN1A, SCNN1B, SCNN1G, SERPINA1, SFTPA2, SFTPB, SFTPC, SLC6A5, SLC7A7, SMAD4, SMAD9, SMPD1, STAT3, STRA6, TERT, TINF2, TSC1, TSC2, ZEB2 |
| Test Details | The Pulmonary Panel NGS Genetic DNA Test is a genetic test that uses next-generation sequencing (NGS) technology to analyze a patient’s DNA for mutations that may be associated with pulmonary diseases. This test can identify mutations in genes that are known to be associated with a variety of pulmonary conditions, including cystic fibrosis, alpha-1 antitrypsin deficiency, and pulmonary hypertension. NGS technology allows for the analysis of multiple genes at once, making it a more efficient and comprehensive approach to genetic testing. The results of the Pulmonary Panel NGS Genetic DNA Test can help physicians diagnose and manage pulmonary diseases, as well as provide information about potential risks for family members. This test is typically ordered for patients with symptoms of pulmonary disease or a family history of pulmonary conditions. It may also be recommended for individuals who are planning to start a family and want to assess their risk for passing on genetic mutations to their children. It is important to note that genetic testing is not a replacement for clinical evaluation and diagnosis by a healthcare professional. The results of genetic testing should be interpreted in the context of a patient’s medical history and other clinical factors. |
